Introducing HPV vaccine in developing countries - Key challenges and issues

被引：218

作者：

Agosti, Jan M. ^{[1
]}

Goldie, Sue J.

机构：

[1] Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA

[2] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2007年 / 356卷 / 19期

关键词：

D O I：

10.1056/NEJMp078053

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1908 / 1910

页数：3

共 5 条

[1] HPV type-distribution in women with and without cervical neoplastic diseases [J].

Clifford, Gary ;

Franceschi, Silvia ;

Diaz, Mireia ;

Munoz, Nubia ;

Villa, Luisa Lina .

VACCINE, 2006, 24 :26-34

[2] Modelling the impact of HPV vaccines on cervical cancer and screening programmes [J].

Garnett, Geoffrey P. ;

Kim, Jane J. ;

French, Katherine ;

Goldie, Sue J. .

VACCINE, 2006, 24 :178-186

[3] Cost-effectiveness of cervical-cancer screening in five developing countries [J].

Goldie, SJ ;

Gaffikin, L ;

Goldhaber-Fiebert, JD ;

Gordillo-Tobar, A ;

Levin, C ;

Mahé, C ;

Wright, TC .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2158-2168

[4] The burden of HPV-related cancers [J].

Parkin, D. Maxwell ;

Bray, Freddie .

VACCINE, 2006, 24 :11-25

[5] A critical assessment of screening methods for cervical neoplasia [J].

Sankaranarayanan, R ;

Gaffikin, L ;

Jacob, M ;

Sellors, J ;

Robles, S .

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2005, 89 :S4-S12

← 1 →